Outcomes of percutaneous coronary intervention among elderly patients in cardiogenic shock: A multicenter, decade-long experience

Journal of Invasive Cardiology

Volumn 15, Issue 7, 2003, Pages 380-384

  Dauerman, Harold L ^a   Ryan Jr , Thomas J ^b   Piper, Winthrop D ^c   Kellett, Mirle A ^b   Shubrooks, Samuel J ^d   Robb, John F ^c   Hearne, Michael J ^e   Watkins, Matthew W ^a   Hettleman, Bruce D ^c   Theodore Silver, M ^f   Niles, Nathaniel W ^c   Malenka, David J ^c  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b MAINE MEDICAL CENTER   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e CATHOLIC MEDICAL CENTER   (United States)

^f EASTERN MAINE MEDICAL CENTER   (United States)

Author keywords

Cardiogenic shock; Coronary stenting; Elderly

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

AGED; ARTICLE; CARDIOGENIC SHOCK; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY STENT; DIABETES MELLITUS; EXPERIENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTION; REGISTER; SENESCENCE; SURGICAL TECHNIQUE; SURVIVAL; TIME; TREATMENT OUTCOME; UNITED KINGDOM;

AGE FACTORS; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEW ENGLAND; PROSPECTIVE STUDIES; REGISTRIES; SHOCK, CARDIOGENIC; STENTS; TREATMENT OUTCOME;

EID: 0038502005     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Goldberg RJ, Samad NA, Yarzebski J, et al. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999;340:1162-1168.
2. Berger PB, Holmes DR Jr., Stebbins AL, et al. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study. Circulation 1997;96:122-127.
3. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. The Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock? (SHOCK) Investigators. N Engl J Med 1999;341:625-634.
4. Dauerman HL, Goldberg RJ, Malinski M, et al. Outcomes and early revascularization for patients ≥ 65 years of age with cardiogenic shock. Am J Cardiol 2001;87:844-848.
5. Smith SC Jr., Dove JT, Jacobs AK, et al. ACC/AHA Guidelines of Percutaneous Coronary Interventions (revision of the 1993 PTCA guidelines) Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol 2001;37:2215-2238.
6. Hasdai D, Holmes DR Jr., Califf RM, et al. Cardiogenic shock complicating acute myocardial infarction: Predictors of death. The Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries (GUSTO) Investigators. Am Heart J 1999;138:21-31.
7. O'Connor GT, Malenka DJ, Quinton H, et al. Multivariate prediction of in-hospital mortality after percutaneous coronary interventions in 1994-1996. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 1999;34:681-691.
8. Malenka DJ, O'Connor GT, Quinton H, et al. Differences in outcomes between women and men associated with percutaneous transluminal coronary angioplasty. A regional prospective study of 13,061 procedures. Northern New England Cardiovascular Disease Study Group. Circulation 1996;94:11-9941-104.
9. Niles NW, McGrath PD, Malenka D, et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: Results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 2001;37:1008-1015.
10. Goldberg RJ, Gore JM, Thompson CA, Gurwitz JH. Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: The second national registry of myocardial infarction. Am Heart J 2001;141:65-72.
11. Webb JG, Sleeper LA, Buller CE, et al. Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: A report from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock? (SHOCK) Trial Registry. J Am Coll Cardiol 2000;36:1084-1090.
12. Dauerman HL, Goldberg RJ, White K, et al. Revascularization, stenting and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 2002;90:838-842.
13. Detre KM, Guo P, Holubkov R, et al. Coronary revascularization in diabetic patients: A comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1999;99:633-640.
14. Kuntz RE. Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: The diabetes-percutaneous transluminal coronary angioplasty dilemma. Circulation 1999;99:847-851.
15. Klein LW, Block P, Brindis RG, et al. Percutaneous coronary interventions in octogenarians in the American College of Cardiology-National Cardiovascular Data Registry. Development of a nomogram predictive of in-hospital mortality. J Am Coll Cardiol 2002;40:394-402.
16. Azar RR, Prpic R, Ho KK, et al. Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 2000;86:485-489.
17. Rubenstein MH, Harrell LC, Sheynberg BV, et al. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation 2000;102:2966-2972.
18. Wennberg DE, Makenka DJ, Sengupta A, et al. Percutaneous transluminal coronary angioplasty in the elderly: Epidemiology, clinical risk factors, and in-hospital outcomes. The Northern New England Cardiovascular Disease Study Group. Am Heart J 1999;137:639-645.
19. Chauhan MS, Kuntz RE, Ho KL, et al. Coronary artery stenting in the aged. JAm Coll Cardiol 2001;37:856-862.
20. Chan AW, Chew DP, Bhatt DL, et al. Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 2002;89:132-136.